Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data
出版年份 2021 全文链接
标题
Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data
作者
关键词
Rheumatic diseases, COVID-19, Outcomes, SARS-CoV-2
出版物
AUTOIMMUNITY REVIEWS
Volume -, Issue -, Pages 102778
出版商
Elsevier BV
发表日期
2021-02-21
DOI
10.1016/j.autrev.2021.102778
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- On the use of corticosteroids for 2019-nCoV pneumonia
- (2020) Lianhan Shang et al. LANCET
- Responding to Covid-19 — A Once-in-a-Century Pandemic?
- (2020) Bill Gates NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine
- (2020) Emanuele Bozzalla Cassione et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China
- (2020) Cong Ye et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
- (2020) Sara Monti et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’
- (2020) Kristin M D’Silva et al. ANNALS OF THE RHEUMATIC DISEASES
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2020) Milena Gianfrancesco et al. ANNALS OF THE RHEUMATIC DISEASES
- Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
- (2020) Yvan Jamilloux et al. AUTOIMMUNITY REVIEWS
- Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms
- (2020) Federica Raucci et al. AUTOIMMUNITY REVIEWS
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
- (2020) Paola Toniati et al. AUTOIMMUNITY REVIEWS
- COVID-19 with rheumatic diseases: a report of 5 cases
- (2020) Chuanfang Cheng et al. CLINICAL RHEUMATOLOGY
- Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy
- (2020) Luca Quartuccio et al. JOINT BONE SPINE
- Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
- (2020) Rebecca Haberman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phylogenetic network analysis of SARS-CoV-2 genomes
- (2020) Peter Forster et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- COVID-19 in Rheumatic Disease Patients on Immunosuppressive Agents
- (2020) Saika Sharmeen et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs
- (2020) Khalil Ansarin et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study
- (2020) Jose L Pablos et al. ANNALS OF THE RHEUMATIC DISEASES
- COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine
- (2020) Cheng Lay Teh et al. ANNALS OF THE RHEUMATIC DISEASES
- Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD
- (2020) Maurizio Benucci et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study
- (2020) Yao Huang et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia
- (2020) Sharifah Aishah Wan et al. ANNALS OF THE RHEUMATIC DISEASES
- No increased rate of SARS-CoV-2 infection for patients with inflammatory rheumatic diseases compared with the general population in the city of Hamburg (Germany)
- (2020) Peer Aries et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases
- (2020) Dalifer D Freites Nuñez et al. ANNALS OF THE RHEUMATIC DISEASES
- Implications of SARS-CoV-2 infection for patients with rheumatic disease
- (2020) Changsong Lin et al. ANNALS OF THE RHEUMATIC DISEASES
- Covid-19 and autoimmunity
- (2020) Michael Ehrenfeld et al. AUTOIMMUNITY REVIEWS
- The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
- (2020) Dennis McGonagle et al. AUTOIMMUNITY REVIEWS
- Determinants of COVID-19 disease severity in patients with underlying rheumatic disease
- (2020) C. Sieiro Santos et al. CLINICAL RHEUMATOLOGY
- COVID ‐19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain
- (2020) Rubén Queiro Silva et al. Dermatologic Therapy
- No Systemic Lupus Erythematosus with COVID-19 in Hong Kong: The Effect of Masking?
- (2020) Ho So et al. JOURNAL OF RHEUMATOLOGY
- Antecedent Immunosuppressive Therapy for Immune-Mediated Inflammatory Diseases in the Setting of a COVID-19 Outbreak
- (2020) Jesse Veenstra et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Ethnic disparities in COVID-19 mortality: are comorbidities to blame?
- (2020) Krithi Ravi LANCET
- Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
- (2020) Alexandre B. Cavalcanti et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs
- (2020) Xabier Michelena et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Leveraging the United States Epicenter to Provide Insights on COVID‐19 in Patients with Systemic Lupus Erythematosus
- (2020) Ruth Fernandez‐Ruiz et al. Arthritis & Rheumatology
- Incidence of COVID‐19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?
- (2020) Ennio Giulio Favalli et al. Arthritis & Rheumatology
- American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 2
- (2020) Ted R. Mikuls et al. Arthritis & Rheumatology
- COVID‐19 infection in patients with systemic lupus erythematosus: Data from the Asia Pacific Lupus Collaboration
- (2020) Jiacai Cho et al. International Journal of Rheumatic Diseases
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
- (2018) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis
- (2015) Camille Roubille et al. ANNALS OF THE RHEUMATIC DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started